Source:http://linkedlifedata.com/resource/pubmed/id/16930515
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2006-8-25
|
pubmed:abstractText |
Transgenic animal mammary gland bioreactors are used to produce recombinant proteins. However, it is difficult to validate whether these transgenic domestic animals are able to express the recombinant protein efficiently in their mammary glands before the birth of transgenic offspring. In the present study, a simple and efficient method was established to evaluate the functionality of animal mammary gland tissue-expressed cassettes. The gene transfer vector pGBC2LF was constructed, and the expression of human lactoferrin (LF) gene was controlled by the goat beta-casein gene 5' flanking sequence. To obtain the most efficient transfection, the influence of DNA concentration, dimethylsulfoxide (DMSO) concentration, and the ratio of linear-to-circular DNA required for associating DNA with spermatozoa were evaluated. Transfection of exogenous DNA into rabbit spermatozoa was found to be efficient using 30 microg mL(-1) DNA, DMSO at a final concentration of 3%, and a 3 : 1 ratio of linear-to-circular DNA, with 29 of 85 (34.1%) in vitro-fertilised embryos being transgenic. Using DMSO-sperm-mediated gene transfer (DMSO-SMGT), 89 rabbit offspring were produced, with 46 of these (57.1%) being transgenic. As mammary gland bioreactor models, 17 of 21 (81%) transgenic female rabbits could express human LF protein in their glands. During lactation of the transgenic rabbits, the highest level of human LF protein expressed was 153 +/- 31 microg mL(-1), and the mean expression level in all of the transgenic rabbits was 103 +/- 20 microg mL(-1) in the third week, declining gradually after this time. Our results demonstrate that transgenic rabbits produced by DMSO-SMGT were able to express human LF protein in the correct tissue.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1031-3613
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
689-95
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16930515-Animals,
pubmed-meshheading:16930515-Animals, Genetically Modified,
pubmed-meshheading:16930515-Bioreactors,
pubmed-meshheading:16930515-Caseins,
pubmed-meshheading:16930515-DNA,
pubmed-meshheading:16930515-Dimethyl Sulfoxide,
pubmed-meshheading:16930515-Female,
pubmed-meshheading:16930515-Fertilization in Vitro,
pubmed-meshheading:16930515-Gene Expression,
pubmed-meshheading:16930515-Goats,
pubmed-meshheading:16930515-Humans,
pubmed-meshheading:16930515-Lactoferrin,
pubmed-meshheading:16930515-Male,
pubmed-meshheading:16930515-Mammary Glands, Animal,
pubmed-meshheading:16930515-Polymerase Chain Reaction,
pubmed-meshheading:16930515-Rabbits,
pubmed-meshheading:16930515-Spermatozoa,
pubmed-meshheading:16930515-Transfection
|
pubmed:year |
2006
|
pubmed:articleTitle |
Human lactoferrin transgenic rabbits produced efficiently using dimethylsulfoxide-sperm-mediated gene transfer.
|
pubmed:affiliation |
Institute of Animal Reproduction, Development and Genetic Engineering, Department of Animal Sciences and Technology, Laiyang Agricultural University, Chengyang, Qingdao 266109, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|